UCB S.A.
- Targets
- 2
- Filings
- 3
- Median premium
- 111%
- First filing
- Nov 1, 2019
- Latest filing
- Feb 1, 2022
Targets
| Company | Score before deal | Score now | Filings | Latest |
|---|---|---|---|---|
| ZOGENIX, INC. | 2 / 7 | — | 1 | Feb 1, 2022 |
| Ra Pharmaceuticals, Inc. | — | — | 2 | Nov 15, 2019 |
| Company | Score before deal | Score now | Filings | Latest |
|---|---|---|---|---|
| ZOGENIX, INC. | 2 / 7 | — | 1 | Feb 1, 2022 |
| Ra Pharmaceuticals, Inc. | — | — | 2 | Nov 15, 2019 |